Catapult Programmes Aim to Accelerate Regenerative Medicine

摘要

The Cell Therapy Catapult is working with multiple-partners to deliver health and wealth to the UK through support from Innovate UK, formerly the Technology Strategy Board. Recently announced projects include an agreement with Plasticell which has brought additional investment to a therapeutic programme utilising CombiCult~R, a high throughput stem cell technology designed to solve bottlenecks in regenerative medicine development. A consortium, including the University of Oxford, are developing a process to expand cord blood stem cells ex vivo using Plasticell's media, thus allowing more patients to be treated with potentially life-saving therapies.